EFFICACY OF COMBINATION THERAPY USING NEBIVALOL AND TRIMETAZIDINE IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION AND STABLE ANGINA

The aim of this study was to evaluate the efficacy of beta – blocker nebivalol alone or in combination with metabolic agent trimetazidine in patients with isolated systolic hypertension (ISH) and stable angina (SA).

Publication Details

Journal: Zenodo (CERN European Organization for Nuclear Research)
Published: 2025-09-15
DOI: https://doi.org/10.5281/zenodo.17118617
Primary Topic: Geochemistry and Geologic Mapping
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

EFFICACY OF COMBINATION THERAPY USING NEBIVALOL AND TRIMETAZIDINE IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION AND STABLE ANGINA

Sep 15, 2025

Zenodo (CERN European Organization for Nuclear Research)

Geochemistry and Geologic Mapping

article

EFFICACY OF COMBINATION THERAPY USING NEBIVALOL AND TRIMETAZIDINE IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION AND STABLE ANGINA

September 15, 2025article en

Abstract

Zenodo (CERN European Organization for Nuclear Research)

Good health and well-being

Openalex Percentile: Top 43%

Geochemistry and Geologic Mapping

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

EFFICACY OF COMBINATION THERAPY USING NEBIVALOL AND TRIMETAZIDINE IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION AND STABLE ANGINA · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS